Skip to content
Breaking
Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment
Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests
Bradyzoite subtypes rule the crossroads of Toxoplasma development
Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund
Welcoming Three New Leaders to the CureSearch Board of Directors
A Pan-Canadian Team Develops Revolutionary Egg-Based Tumor Model for Rapid, Personalized Cancer Treatment Discovery
Estrogen Hormone Regulates Female Binge Drinking, Driving Rapid Alcohol Consumption and Contributing to Sex Differences in Behavior
Routine Calcium and Vitamin D Supplementation Offers Little Benefit Against Falls and Fractures for Most Older Adults, Major Review Concludes
The Dual Nature of a Crucial Enzyme: PI3K Possesses Both Accelerator and Brake for Cell Migration
Genetically Tailored Treatment Plans for Children with Wilms Tumour Promise More Effective Care and Minimized Side Effects
21 Sep 2026, Mon
Cancerilles

Cancerilles

Knowledge and News for the Global Fight Against Cancer.

  • Home
  • About Us
    • About Us
    • Advertising Policy
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • DMCA
    • Privacy Policy
    • Terms of Service
  • Contact Us
  • FAQ
  • Sitemap
Biotech, Pharma & Cancer Drug Development

Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment

admin Sep 21, 2026
Hematology, Leukemia & Lymphoma

Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests

Hendra Lukman Sep 21, 2026
Biotech, Pharma & Cancer Drug Development

Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment

admin Sep 21, 2026
Hematology, Leukemia & Lymphoma

Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests

Hendra Lukman Sep 21, 2026
Gynecologic Oncology (Ovarian, Cervical)

Bradyzoite subtypes rule the crossroads of Toxoplasma development

George Ongkojoyo Sep 21, 2026
Pediatric Oncology & Childhood Cancers

Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund

admin Sep 21, 2026
Uncategorized

Welcoming Three New Leaders to the CureSearch Board of Directors

admin Sep 21, 2026
Biotech, Pharma & Cancer Drug Development

Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment

Sep 21, 2026
Hematology, Leukemia & Lymphoma

Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests

Sep 21, 2026
Gynecologic Oncology (Ovarian, Cervical)

Bradyzoite subtypes rule the crossroads of Toxoplasma development

Sep 21, 2026
Pediatric Oncology & Childhood Cancers

Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund

Sep 21, 2026
Hematology, Leukemia & Lymphoma

Unlocking Pancreatic Cancer’s Resistance: Duke-NUS Researchers Identify Molecular Switch to Re-sensitize Tumors to Chemotherapy

Hendra Lukman Sep 14, 2026

Singapore – October 26, 2023 – A groundbreaking discovery by researchers at Duke-NUS Medical School...

Gastrointestinal & Colorectal Cancers

Serendipitous Scientific Detour Unlocks Potential for Revolutionizing RNA-Based Therapies

Gilang Cahya Sep 14, 2026

In the relentless pursuit of scientific understanding, unexpected outcomes are not failures, but often the...

Neuro-Oncology (Brain & CNS)

New vitamin B12 therapy shows promise against deadly brain cancer

Nana O Sep 14, 2026

A groundbreaking study published in the prestigious journal Oncoscience has unveiled a promising new avenue...

Genitourinary, Prostate & Kidney Cancer

Innovative Nanoparticle Strategy Offers New Hope for Treating Glioblastoma by Bypassing the Blood-Brain Barrier

Gabriel Paijo Sep 14, 2026

Researchers at Oregon State University have announced a significant breakthrough in the treatment of glioblastoma,...

Gynecologic Oncology (Ovarian, Cervical)

Routine X-rays for Knee Osteoarthritis Fuel Unnecessary Surgeries and Patient Anxiety New Study Finds

George Ongkojoyo Sep 14, 2026

The diagnostic pathway for knee osteoarthritis in Australia is facing intense scrutiny following the release...

Uncategorized

From Childhood Cancer Survivor to Collegiate Athlete The Inspiring Journey of Stevie Elam

admin Sep 14, 2026

Stevie Elam’s journey from a life-threatening diagnosis at age three to a standout collegiate basketball...

Skin Cancer, Melanoma & Dermatology

UVA Health Researchers Uncover How Brain-Infecting Parasites Are Controlled by Immune Cell Self-Destruction

Suherman Candra Maholtra Sep 14, 2026

The human brain, protected by the formidable blood-brain barrier and a complex network of specialized...

Biotech, Pharma & Cancer Drug Development

AstraZeneca’s Oral SERD Etcamah Fails Key First-Line Breast Cancer Trial, Raising Questions for Broader Market Ambitions

admin Sep 14, 2026

AstraZeneca, the Anglo-Swedish pharmaceutical giant, announced on Friday, September 14, 2026, a significant setback for...

Hematology, Leukemia & Lymphoma

Low Vitamin D Levels Linked to Increased Postoperative Pain and Opioid Use After Breast Cancer Surgery

Hendra Lukman Sep 14, 2026

Low vitamin D levels may make recovery from breast cancer surgery more painful and increase...

Gynecologic Oncology (Ovarian, Cervical)

Breakthrough Research at UC Santa Barbara Unveils Novel Antibody Therapy for Polycystic Kidney Disease

George Ongkojoyo Sep 14, 2026

Researchers at the University of California, Santa Barbara (UCSB) have announced a significant advancement in...

Posts pagination

1 … 31 32 33 … 365

Posts Carousel

Biotech, Pharma & Cancer Drug Development

Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment

admin Sep 21, 2026
Hematology, Leukemia & Lymphoma

Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests

Hendra Lukman Sep 21, 2026
Gynecologic Oncology (Ovarian, Cervical)

Bradyzoite subtypes rule the crossroads of Toxoplasma development

George Ongkojoyo Sep 21, 2026
Pediatric Oncology & Childhood Cancers

Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund

admin Sep 21, 2026
Uncategorized

Welcoming Three New Leaders to the CureSearch Board of Directors

admin Sep 21, 2026
Trending
Popular
Latest
Biotech, Pharma & Cancer Drug Development
Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment
Sep 21, 2026
Hematology, Leukemia & Lymphoma
Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests
Sep 21, 2026
Gynecologic Oncology (Ovarian, Cervical)
Bradyzoite subtypes rule the crossroads of Toxoplasma development
Sep 21, 2026
Pediatric Oncology & Childhood Cancers
Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund
Sep 21, 2026
Biotech, Pharma & Cancer Drug Development
Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment
Sep 21, 2026
Hematology, Leukemia & Lymphoma
Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests
Sep 21, 2026
Gynecologic Oncology (Ovarian, Cervical)
Bradyzoite subtypes rule the crossroads of Toxoplasma development
Sep 21, 2026
Pediatric Oncology & Childhood Cancers
Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund
Sep 21, 2026
Biotech, Pharma & Cancer Drug Development
Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment
Sep 21, 2026
Hematology, Leukemia & Lymphoma
Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests
Sep 21, 2026
Gynecologic Oncology (Ovarian, Cervical)
Bradyzoite subtypes rule the crossroads of Toxoplasma development
Sep 21, 2026
Pediatric Oncology & Childhood Cancers
Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund
Sep 21, 2026

You Missed

Biotech, Pharma & Cancer Drug Development

Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment

Hematology, Leukemia & Lymphoma

Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests

Gynecologic Oncology (Ovarian, Cervical)

Bradyzoite subtypes rule the crossroads of Toxoplasma development

Pediatric Oncology & Childhood Cancers

Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund

Cancerilles

Cancerilles

Knowledge and News for the Global Fight Against Cancer.

Copyright © All rights reserved | Newspaperup by Themeansar.

  • Home
  • About Us
    • About Us
    • Advertising Policy
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • DMCA
    • Privacy Policy
    • Terms of Service
  • Contact Us
  • FAQ
  • Sitemap

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.